Sitemap
Pages
Categories
Tags
NoneEpisodes
- EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?
- Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?
- Ep 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing
- Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change
- Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy
- Ep 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, and Engagement
- Ep 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026
- Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds
- Ep 34 | ACNU Explained: How FDA’s New Nonprescription Pathway Could Expand Access and Improve Adherence
- Ep 33 | Year in Review: The Healthcare Shifts That Defined 2025 and What’s Ahead in 2026
- Ep 32 | Exploring AI Patient Care and Clinical Decision Making with Carole Tremonti
- Ep 31 | The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next
- Ep 30 | ACNU Live Panels Follow-Up: Deep Dive Virtual Panel On FDA’s New ACNU Rule
- Ep 29 | The Future of the Journal of Clinical Pathways with Winston Wong
- Ep 28 | Insights from Health Rosetta Fest 2025
- OHPLive! | Nicholas Hall Panel Discussion 2: Nonprescription Access to Drug Treatment
- OHPLive! | Nicholas Hall Panel Discussion 1_Non prescription access to drug treatment.mp4
- Breaking Down the $80 Billion 340B Drug Program with William Sarraille | Only Healthcare Podcast #25
- How Cell and Gene Therapies Can Bankrupt Unprepared Employers with Tom Sondergeld | Only Healthcare Podcast #24
- Healthcare’s Lightning Strike Cost Problem with Drew Wilkins | Only Healthcare Podcast #23
- The Hidden Agenda of Healthcare Insurance with Tamara Thomas | Only Healthcare Podcast #22
- Breaking the Healthcare Monopoly with Dave Chase and Steve Ditto | Only Healthcare Podcast #21
- GLP-1s: The Billion Dollar Dilemma in US Healthcare with Deborah Williams | Only Healthcare Podcast #20
- Why Are Prescription Drugs So Expensive with Michael Navin & Dr. Randy Vogenberg | Only Healthcare Podcast #19
- Why the US Spends the Most on Healthcare But Gets the Worst Outcomes with Dr. Randy Vogenberg & Michael Navin | Only Healthcare Podcast #18
- Secrets to Solutions: How Real-Time Pricing Data Can Heal Healthcare
- Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?
- Confronting the Affordability Crisis: Unmasking the True Cost of Healthcare
- Clear Costs, Clearer Choices: Unpacking Trump’s Transparency Drive in Healthcare
- Policy and Power: Dismantling Middleman Dominance in Healthcare
- Rethinking Risk: Innovating Benefit Design for Whole-Person Care
- Navigating the Future of Healthcare Policy
- Transforming Healthcare: Innovations in Clinical Pathways with Dr. Randy Vogenberg
- What Can Be Done to Bridge the Gap Between Employer-Manufacturer Collaboration
- Unlocking Access and Collaboration: The Benefits of Employer-Pharma Relationships
- How Employer-Pharmaceutical Collaboration Can Transform Healthcare Plans
- Navigating State-Level Legislation & The Future of Patient-Centered Care
- Ask The Expert with Michael Navin: Unpacking the Latest Prescription Lawsuits
- GLP-1 Drugs: Rapid Growth and Market Evolution
- Ask the Expert with Dr. Randy Vogenberg: How Government Policies Influence Commercial Insurance Implications
- How Employer Decisions Impact Coverage & Reimbursement
- Exploring Healthcare Stakeholder Interactions
Receive UPdates to my inbox.
The Only Healthcare podcast is available for free streaming on the Red Coral Universe app or wherever you stream your podcasts.
Copyright 2026 Only Healthcare.
All rights reserved.